Common Sugar May Loosen Cancer Cells and Help Them Spread

A groundbreaking study from The Wistar Institute has uncovered a surprising and concerning link between a common dietary sugar and the spread of ovarian cancer. The research, published in the journal Nature Aging, suggests that fructose—a sugar widely consumed in fruits, honey, and processed foods via high-fructose corn syrup—may act as a chemical signal that encourages cancer cells to break free from tumors and metastasize . The findings add a new layer of complexity to understanding why ovarian cancer, which is initially responsive to platinum-based chemotherapy, recurs and spreads in the vast majority of patients, ultimately causing about 90% of deaths from the disease .

The Unexpected Role of Chemotherapy-Surviving Cells

The research team, led by Dr. Katherine Aird and first author Dr. Aidan Cole, focused on a phenomenon called cellular senescence. When ovarian cancer cells are treated with standard chemotherapy drugs like cisplatin, many die, but some enter a dormant "zombie-like" state where they stop dividing but remain biologically active . While scientists have known these senescent cells secrete various molecules, this study is among the first to show that a nutrient can act as a primary signaling molecule driving metastasis.

The researchers collected the chemical mixture released by chemotherapy-surviving cells and exposed other cancer cells to it. Remarkably, this mixture alone—without the senescent cells themselves—was enough to significantly increase the cancer cells' ability to detach and spread in preclinical models . "As far as we know, this is the first time anyone has shown, in a preclinical model rather than just a dish, that it's the molecules these cells release—not the cells themselves—that drive the cancer's spread," said Cole .

Fructose as a Metastatic Signal

Through detailed chemical analysis, the team identified fructose as a key component of the signal. They found that surviving cancer cells consume large amounts of glucose and convert it into fructose, which they then release . When researchers added fructose alone to cancer cells that had never been exposed to senescent fluid, it was enough to trigger the same breakaway behavior, confirming its role as a direct driver of detachment .

Even more striking, the effects were not limited to chemotherapy-induced signals. The study found that high dietary fructose intake—comparable to levels found in sugary drinks—could encourage cancer spread in animal models even without chemotherapy . In the United States, high-fructose corn syrup accounts for approximately 8-20% of daily calorie intake for some individuals, raising significant questions about diet's influence on cancer progression .

The Molecular Mechanism: Cholesterol and Cellular "Glue"

The team delved into how fructose exerts its effect on cancer cells. Using advanced techniques including a CRISPR screen, they discovered that fructose acts by suppressing cholesterol production inside the cancer cells . Cholesterol plays a crucial role in maintaining cell membrane structure and acts like "biological glue" that keeps cells attached to one another. When fructose causes cholesterol levels to fall, these bonds weaken, allowing cancer cells to separate more easily and migrate to other parts of the body .

This mechanistic insight led to an unexpected concern about a common class of drugs. Statins, which are taken by approximately 39 million people in the U.S., work by lowering cholesterol production. In the study, statins alone weakened the connections between cancer cells and made it easier for them to escape, similar to the effect of fructose . The researchers emphasize that these findings are preliminary and not a reason for patients to stop taking prescribed statins, but they raise important clinical questions about combining cholesterol-lowering drugs with chemotherapy.

"Ovarian cancer is most common in postmenopausal women who are often already on statins," noted Dr. Aird. "We haven't tested this effect in patients yet, but it raises important questions" .

Potential Implications and Future Research

The study opens several promising avenues for future research and potential therapeutic strategies. Drugs that selectively clear out senescent cells are already being studied in cancer, and this research provides a stronger rationale for pursuing them in ovarian cancer . Dietary interventions, such as reducing fructose intake during or after chemotherapy, are another idea the authors raise, though they are careful to stress that this requires clinical testing .

The researchers are also investigating whether this same fructose-related pathway could play a role in other cancers that commonly spread within the torso, such as pancreatic, colon, and liver cancers. While they cannot yet call it a universal mechanism, they believe the effects are not limited to ovarian cancer . The team has already begun planning follow-up studies to test these hypotheses.

Important Caveats for Patients

The authors and independent experts stress several crucial limitations. The findings come primarily from cells and animal models; they do not show that fructose causes cancer spread in people or that any dietary or treatment change is warranted . The animal experiments used a single cell line, limiting the breadth of the findings, and the aggressive nature of that cell line made it impossible to assess the impact on progression-free survival .

Furthermore, the mechanism by which fructose activates the energy-making machinery in cells remains unresolved, and the potential indirect effects through the gut microbiome and liver metabolism were not determined . Importantly, the researchers have not tested the effects of reducing fructose consumption in patients, and one experiment with an NAD+ precursor should not be interpreted as advice regarding supplement use .

"This is not a reason to avoid chemotherapy. Platinum-based chemotherapy remains the standard treatment for this cancer," emphasizes the research team . Anyone with questions about cancer treatment, statin use, or dietary changes should consult their oncologist.

Conclusion

The Wistar Institute study provides a compelling, if unsettling, look at the complex interplay between cancer treatment and tumor biology. By revealing that chemotherapy-surviving cancer cells can use the common sugar fructose to promote metastasis, it highlights a previously overlooked pathway that may influence ovarian cancer recurrence and progression. The research also raises important questions about the potential interactions between widely used drugs like statins and cancer treatments. While these findings are preliminary and require extensive clinical validation, they open new avenues of investigation into how diet and common medications might influence cancer outcomes, potentially leading to more effective strategies to prevent ovarian cancer from returning and spreading .